Shefferman Jesse has filed 20 insider transactions across 1 company since January 2024.
Most recent transaction: a tax payment of 8732 shares of Protara Therapeutics, Inc. ($PRTO) on January 26, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 26, 2026 | Protara Therapeutics, Inc. | $PRTO | Shefferman Jesse | CEO and President | F | Common Stock | 8732 | $6.67 | 1,021,832.0000 | 42,272,104 | 0.85% | 0.02% |
| Jan. 20, 2026 | Protara Therapeutics, Inc. | $PRTO | Shefferman Jesse | CEO and President | F | Common Stock | 16322 | $5.60 | 1,030,564.0000 | 42,272,104 | 1.56% | 0.04% |
| Jan. 16, 2026 | Protara Therapeutics, Inc. | $PRTO | Shefferman Jesse | CEO and President | A | Common Stock | 87000 | $0.00 | 1,046,886.0000 | 42,272,104 | 9.06% | 0.21% |
| Jan. 16, 2026 | Protara Therapeutics, Inc. | $PRTO | Shefferman Jesse | CEO and President | A | Stock Option (Right to Buy) | 524000 | $0.00 | 524,000.0000 | 42,272,104 | 9999.99% | 1.24% |
| June 24, 2025 | Protara Therapeutics, Inc. | $PRTO | Shefferman Jesse | CEO and President | G | Common Stock | 300000 | $0.00 | 959,886.0000 | 40,707,937 | 23.81% | 0.74% |
| June 27, 2025 | Protara Therapeutics, Inc. | $PRTO | Shefferman Jesse | CEO and President | G | Common Stock | 10200 | $0.00 | 963,253.0000 | 40,707,937 | 1.05% | 0.03% |
| June 27, 2025 | Protara Therapeutics, Inc. | $PRTO | Shefferman Jesse | CEO and President | G | Common Stock | 3367 | $0.00 | 959,886.0000 | 40,707,937 | 0.35% | 0.01% |
| June 26, 2025 | Protara Therapeutics, Inc. | $PRTO | Shefferman Jesse | CEO and President | G | Common Stock | 1700 | $0.00 | 976,853.0000 | 40,707,937 | 0.17% | 0.00% |
| June 26, 2025 | Protara Therapeutics, Inc. | $PRTO | Shefferman Jesse | CEO and President | G | Common Stock | 3400 | $0.00 | 973,453.0000 | 40,707,937 | 0.35% | 0.01% |
| Jan. 24, 2025 | Protara Therapeutics, Inc. | $PRTO | Shefferman Jesse | CEO and President | A | Common Stock | 65000 | $0.00 | 994,022.0000 | 20,592,847 | 7.00% | 0.32% |
| Jan. 24, 2025 | Protara Therapeutics, Inc. | $PRTO | Shefferman Jesse | CEO and President | A | Stock Option (Right to Buy) | 387000 | $0.00 | 387,000.0000 | 20,592,847 | 9999.99% | 1.88% |
| Jan. 21, 2025 | Protara Therapeutics, Inc. | $PRTO | Shefferman Jesse | CEO and President | F | Common Stock | 15469 | $4.76 | 913,553.0000 | 20,592,847 | 1.67% | 0.08% |
| Jan. 3, 2025 | Protara Therapeutics, Inc. | $PRTO | Shefferman Jesse | CEO and President | F | Common Stock | 6479 | $6.14 | 929,022.0000 | 20,592,847 | 0.69% | 0.03% |
| Aug. 28, 2024 | Protara Therapeutics, Inc. | $PRTO | Shefferman Jesse | CEO and President | G | Common Stock | 3300 | $0.00 | 935,501.0000 | 21,233,163 | 0.35% | 0.02% |
| Aug. 28, 2024 | Protara Therapeutics, Inc. | $PRTO | Shefferman Jesse | CEO and President | G | Common Stock | 5263 | $0.00 | 938,801.0000 | 21,233,163 | 0.56% | 0.02% |
| Jan. 19, 2024 | Protara Therapeutics, Inc. | $PRTO | Shefferman Jesse | CEO and President | A | Common Stock | 59000 | $0.00 | 951,867.0000 | 11,331,338 | 6.61% | 0.52% |
| Jan. 19, 2024 | Protara Therapeutics, Inc. | $PRTO | Shefferman Jesse | CEO and President | F | Common Stock | 7803 | $1.91 | 944,064.0000 | 11,331,338 | 0.82% | 0.07% |
| Jan. 19, 2024 | Protara Therapeutics, Inc. | $PRTO | Shefferman Jesse | CEO and President | A | Stock Option (Right to Buy) | 357000 | $0.00 | 357,000.0000 | 11,331,338 | 9999.99% | 3.15% |
| Jan. 10, 2024 | Protara Therapeutics, Inc. | $PRTO | Shefferman Jesse | CEO and President | F | Common Stock | 5746 | $2.39 | 892,867.0000 | 11,331,338 | 0.64% | 0.05% |
| Jan. 3, 2024 | Protara Therapeutics, Inc. | $PRTO | Shefferman Jesse | CEO and President | F | Common Stock | 5840 | $2.17 | 898,613.0000 | 11,331,338 | 0.65% | 0.05% |